Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Replagal Advisory Committee Will Include Closed Door Session On Manufacturing

Feb 27 2012

• By Cathy Dombrowski

Related Content

Fabrazyme Approved; FDA Weighing What Confirmatory Data Will Be Needed

Apr 28 2003

TKT Replagal Surrogate Data Should Be Reworked For Accelerated Approval

Jan 20 2003

Shire/TKT Merger Deal Focuses On Dynepo Rights In Europe

Apr 21 2005

Despite Rival's Supply Problems, No Guarantee That Shire Will Re-File Replagal In U.S.

Apr 13 2011

FDA Inspection Of Genzyme Plant Finds Lack Of Follow-up, Old Equipment, Poor Personnel Qualification

Nov 30 2009

Genzyme/TKT Fabry Agents Receive Co-Exclusive Orphan Drug Status In EU

Aug 13 2001

Related Companies

Takeda Pharmaceutical Co. Ltd.

Sanofi Genzyme

Additional Topics

Advisory Committees

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window